Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nano Mask Issues Corporate Update

Abstract:
Nano Mask, Inc. (Pinksheets:NANM - News) today issued the following corporate update:

-- Testing: All testing conducted on the filter media -- including an H1N1 test -- has been completed and submitted to an independent testing laboratory for analysis. Results are expected within approximately two weeks.

Nano Mask Issues Corporate Update

MANTECA, CA | Posted on September 17th, 2009

-- Manufacturing: Nano Mask has awarded a mask manufacturing contract to a major U.S. based filter media and mask manufacturer. Initial production capacity will be 100,000 masks per day, seven days per week with the capability to increase production. The company has been developing several mask designs and the first design will be ready in the immediate future. The mask manufacturing company to whom the company has awarded its production contract has assisted in design development and will assist in submissions to the relevant regulatory agencies.

-- Distribution: Nano Mask is currently negotiating distributorship agreements with a number of medical products distributors, both domestically and internationally, and expects to enter into definitive agreements shortly.

-- Financials: The company anticipates retaining a public auditing firm to bring its Securities and Exchange Commission filings up to date in a timely manner.

####

About Nano Mask, Inc.
Nano Mask, Inc. is the inventor of the NanoMask, a disposable anti-microbial facemask currently under development in partnership with Intrinsiq Materials USA, Inc. of Menlo Park, California.

Forward-looking Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, the estimated testing period for the NanoMask may need to be adjusted and extended depending on unforeseen circumstances. Any delays may affect the planned timeline for initiating production, registration and actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.

For more information, please click here

Contacts:
Doug Heath
President and CEO
Nano Mask, Inc.
708 D Industrial Park Drive
Manteca, CA 95337

Copyright © Nano Mask, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project